Previous close | 331.60 |
Open | 332.10 |
Bid | 310.00 x N/A |
Ask | 338.00 x N/A |
Day's range | 326.90 - 333.90 |
52-week range | 306.80 - 371.20 |
Volume | |
Avg. volume | 23,058,714 |
Market cap | 29.935B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 27.24 |
EPS (TTM) | 0.12 |
Earnings date | 01 Aug 2024 - 15 Aug 2024 |
Forward dividend & yield | 0.06 (1.81%) |
Ex-dividend date | 14 Mar 2024 |
1y target est | 368.56 |
Dr. Reddy's (RDY) is set to acquire Haleon's leading global NRT brand, Nicotinell, and its related portfolio across all formats of the drug for GBP 500 million to boost its OTC presence worldwide.
HYDERABAD, India, June 26, 2024--Dr. Reddy’s to acquire Nicotinell and related portfolio in significant step towards building global consumer healthcare business
Haleon, the maker of Sensodyne toothpaste, has agreed a £500m deal to sell a major division outside of the US.